Tab Application Banner
  • Users Online: 117
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Reader Login
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2020| Supplement 2  | Volume 15 | Issue 6  
    Online since January 18, 2021

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
Development of the myocite biobank: Cost-efficient model of public sector investigator-driven biobank for idiopathic inflammatory myositis
R Naveen, Anamika Kumari Anuja, Mohit Kumar Rai, Vikas Agarwal, Latika Gupta
Supplement 2 2020, 15(6):194-199
DOI:10.4103/injr.injr_95_20  
  8 1,045 77
Serum fatty acid-binding protein 3 levels differentiate active from inactive myositis and correlate with response to therapy
Latika Gupta, Sanjukta Majumder, Amita Aggarwal, Ramnath Misra, Able Lawrence
Supplement 2 2020, 15(6):187-190
DOI:10.4103/injr.injr_57_20  
  2 868 91
CASE REPORT
Tacrolimus in refractory juvenile dermatomyositis: Case report and review of literature
Anand Prahalad Rao, Vinyasa Kolli, Indhuja Rajarathinam, Jyothi Raghuram
Supplement 2 2020, 15(6):205-208
DOI:10.4103/injr.injr_128_20  
  1 1,098 126
LETTERS TO EDITOR
The muscle rap
Benzeeta Pinto, Sakir Ahmed
Supplement 2 2020, 15(6):225-225
DOI:10.4103/injr.injr_49_20  
  1 232 57
An atypical presentation of antisynthetase syndrome
Mayank Kapoor, Minakshi Dhar, Sukdev Manna
Supplement 2 2020, 15(6):220-221
DOI:10.4103/injr.injr_134_20  
  1 957 91
PERSPECTIVES
Idiopathic inflammatory myopathies: Contributions from India
Anand Narayan Malaviya
Supplement 2 2020, 15(6):209-216
DOI:10.4103/injr.injr_51_20  
  1 1,319 96
REVIEW ARTICLES
Cancer in myositis
Albert Selva-OCallaghan, Maria Terrones-Peinador, Joana Rita Marques-Soares, Albert Gil-Vila
Supplement 2 2020, 15(6):131-136
DOI:10.4103/injr.injr_168_20  
  1 935 90
The clinicoserological spectrum of inflammatory myopathy in the context of systemic sclerosis and systemic lupus erythematosus
John D Pauling, Sarah Skeoch, Julie J Paik
Supplement 2 2020, 15(6):81-90
DOI:10.4103/injr.injr_136_20  
  1 1,559 234
Pathogenesis of muscle weakness in inflammatory myositis
Sai Kumar Dunga, TG Sundaram, Chengappa G Kavadichanda
Supplement 2 2020, 15(6):99-111
DOI:10.4103/injr.injr_120_20  
  1 1,680 163
BRIEF REPORT
Combined case record forms for collaborative datasets of patients and controls of idiopathic inflammatory myopathies
Pankti Mehta, Latika Gupta
Supplement 2 2020, 15(6):191-193
DOI:10.4103/injr.injr_56_20  
  - 66 16
LETTERS TO EDITOR
We are in charge of treating myositis!
Ilke Coskun Benlidayi
Supplement 2 2020, 15(6):226-226
DOI:10.4103/injr.injr_54_20  
  - 1,160 102
Sociocultural challenges in patients with myositis and the unmet need for patient support groups: Perspectives from North India
Rudrarpan Chatterjee
Supplement 2 2020, 15(6):222-224
DOI:10.4103/injr.injr_204_20  
  - 473 67
ORIGINAL ARTICLES
Is polymyositis a rare or over-diagnosed entity? A descriptive follow-up study of patients initially admitted in a tertiary center with the diagnosis of polymyositis
Pablo Arturo Olivo Pallo, Matheus Santos Rodrigues Silva, Fernando Henrique Carlos de Souza, Samuel Katsuyuki Shinjo
Supplement 2 2020, 15(6):180-186
DOI:10.4103/injr.injr_111_20  
  - 814 79
Intravenous immunoglobulin in the management of idiopathic inflammatory myositis: A single centre retrospective review
Jeet Hemantkumar Patel, Lalit Duggal, Ved Chaturvedi, Neeraj Jain, Gurbir Bhandari, Mayank Gupta
Supplement 2 2020, 15(6):200-204
DOI:10.4103/injr.injr_28_20  
  - 1,380 115
PERSPECTIVES
Conquering myositis, beyond remission
Amber OConnor, TG Sundaram
Supplement 2 2020, 15(6):217-219
DOI:10.4103/injr.injr_179_20  
  - 350 48
PREFACE
Inflammatory myositis - Foray into the future
Neil McHugh, Latika Gupta
Supplement 2 2020, 15(6):73-73
DOI:10.4103/0973-3698.238193  
  - 823 173
REVIEW ARTICLES
Bye-bye muscle biopsy, we have autoantibodies with us now
Victoria Riddell, Sarah L Tansley
Supplement 2 2020, 15(6):74-80
DOI:10.4103/injr.injr_114_20  
  - 2,758 292
Juvenile dermatomyositis: Controversies and recent developments in management
Himanshi Chaudhary, Satish Kumar Loganathan, Surjit Singh
Supplement 2 2020, 15(6):112-122
DOI:10.4103/injr.injr_107_20  
  - 1,716 168
Idiopathic inflammatory myopathy: From muscle biopsy to serology
Ritu Verma, Vimal Kumar Paliwal
Supplement 2 2020, 15(6):123-130
DOI:10.4103/injr.injr_165_20  
  - 883 113
Statin-associated muscle disorders
Alan Xu, Vidya Limaye
Supplement 2 2020, 15(6):137-144
DOI:10.4103/injr.injr_81_20  
  - 466 126
Sporadic inclusion body myositis in the rheumatology clinic
Fernando Henrique Carlos de Souza, Gustavo Luiz Behrens Pinto, Jean Marcos de Souza, Pablo Arturo Olivo Pallo, Leonardo Santos Hoff, Samuel Katsuyuki Shinjo
Supplement 2 2020, 15(6):145-152
DOI:10.4103/injr.injr_80_20  
  - 1,409 118
Emerging therapeutics in idiopathic inflammatory myopathy
Shinji Sato
Supplement 2 2020, 15(6):153-162
DOI:10.4103/injr.injr_124_20  
  - 964 119
The evolving spectrum of interstitial lung disease in myositis—Management pearls
Takahisa Gono
Supplement 2 2020, 15(6):163-174
DOI:10.4103/injr.injr_118_20  
  - 835 100
Assistive devices: Regaining mobility in myositis
Samira Davalbhakta, Akshay Oswal, Sanat Phatak
Supplement 2 2020, 15(6):175-179
DOI:10.4103/injr.injr_90_20  
  - 1,299 92
Picking interstitial lung disease out of the myositis haystack
Jennifer Hannah, Harsha Gunawardena
Supplement 2 2020, 15(6):91-98
DOI:10.4103/injr.injr_189_20  
  - 1,154 157